Choco
"For Instant and Affordable Diagnosis"
CHOCO is a pre-screening tool of CHS that provides ANML based early detection of COVID-19 and other abnormalities in Chest X-Ray. Our initial analysis based on data from other parts of the world provides a baseline accuracy of 82%. Testing the prototype on Indian COVID-19 data sample has shown accuracy exceeding 93%. CHS is in discussions with partner medical institution(s) to do clinical tests. CXR is also the first imaging investigation of choice with any patient presenting respiratory complaints or fever. CHOCO therefore has a great potential to be used as an adjunct-screening tool along with RT-PCR. Fast. round the dock accurate reporting of CXR will be required to get the best results The software helps as a force multiplier and enhances faster and effective mass screening at a time of crisis.
